These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18003545)

  • 1. The "Oncosimulator": a multilevel, clinically oriented simulation system of tumor growth and organism response to therapeutic schemes. Towards the clinical evaluation of in silico oncology.
    Stamatakos GS; Dionysiou DD; Graf NM; Sofra NA; Desmedt C; Hoppe A; Uzunoglu NK; Tsiknakis M
    Annu Int Conf IEEE Eng Med Biol Soc; 2007; 2007():6629-32. PubMed ID: 18003545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'In silico' oncology for clinical decision making in the context of nephroblastoma.
    Graf N; Hoppe A; Georgiadi E; Belleman R; Desmedt C; Dionysiou D; Erdt M; Jacques J; Kolokotroni E; Lunzer A; Tsiknakis M; Stamatakos G
    Klin Padiatr; 2009; 221(3):141-9. PubMed ID: 19437361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The technologically integrated oncosimulator: combining multiscale cancer modeling with information technology in the in silico oncology context.
    Stamatakos G; Dionysiou D; Lunzer A; Belleman R; Kolokotroni E; Georgiadi E; Erdt M; Pukacki J; Rüeping S; Giatili S; d'Onofrio A; Sfakianakis S; Marias K; Desmedt C; Tsiknakis M; Graf N
    IEEE J Biomed Health Inform; 2014 May; 18(3):840-54. PubMed ID: 24108720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards in silico oncology: adapting a four dimensional nephroblastoma treatment model to a clinical trial case based on multi-method sensitivity analysis.
    Georgiadi ECh; Dionysiou DD; Graf N; Stamatakos GS
    Comput Biol Med; 2012 Nov; 42(11):1064-78. PubMed ID: 23063290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploiting clinical trial data drastically narrows the window of possible solutions to the problem of clinical adaptation of a multiscale cancer model.
    Stamatakos GS; Georgiadi EC; Graf N; Kolokotroni EA; Dionysiou DD
    PLoS One; 2011 Mar; 6(3):e17594. PubMed ID: 21407827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of children with Wilms' tumor.
    D'Angio GJ
    Cancer; 1972 Dec; 30(6):1528-33. PubMed ID: 4345097
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy in the treatment of leukemia and Wilms' tumor.
    Farber S
    JAMA; 1966 Nov; 198(8):826-36. PubMed ID: 4288581
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of chemotherapy on the Wistar-Furth Wilms' Tumor.
    Murphy GP; Williams PD
    J Med; 1975; 6(5-6):401-10. PubMed ID: 176292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nephroblastoma, model of childhood cancer responding to chemotherapy].
    Lemerle J; Tournade MF; Pein F
    Bull Acad Natl Med; 1998; 182(6):1231-43; discussion 1243-6. PubMed ID: 9812409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Older age is an adverse prognostic factor in stage I, favorable histology Wilms' tumor treated with vincristine monochemotherapy: a study by the United Kingdom Children's Cancer Study Group, Wilm's Tumor Working Group.
    Pritchard-Jones K; Kelsey A; Vujanic G; Imeson J; Hutton C; Mitchell C; ;
    J Clin Oncol; 2003 Sep; 21(17):3269-75. PubMed ID: 12947062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative chemotherapy in Wilms' tumour. Results of clinical trials and studies on nephroblastomas conducted by the International Society of Paediatric Oncology (SIOP).
    de Kraker J; Voûte PA; Lemerle J; Tournade MF; Perry HJ
    Prog Clin Biol Res; 1982; 100():131-44. PubMed ID: 6292926
    [No Abstract]   [Full Text] [Related]  

  • 12. In silico oncology: exploiting clinical studies to clinically adapt and validate multiscale oncosimulators.
    Stamatakos GS; Kolokotroni E; Dionysiou D; Veith C; Kim YJ; Franz A; Marias K; Sabczynski J; Bohle R; Graf N
    Annu Int Conf IEEE Eng Med Biol Soc; 2013; 2013():5545-9. PubMed ID: 24110993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vincristine in primary treatment of Wilms' tumor.
    Sutow WW; Sullivan MP
    Tex Med; 1965 Nov; 61(11):794-9. PubMed ID: 4284794
    [No Abstract]   [Full Text] [Related]  

  • 14. Vincristine (NSC-67574) therapy for Wilms' tumor.
    Sullivan MP
    Cancer Chemother Rep; 1968 Jun; 52(4):481-4. PubMed ID: 4317500
    [No Abstract]   [Full Text] [Related]  

  • 15. [Progress in the treatment of children with Wilms' tumor in the Department of Pediatric Oncology at the Institute of Mother and Child].
    Perek D; Dembowska-Bagińska B; Jurczyk-Procyk S; Zelazowski J
    Pediatr Pol; 1996 Aug; 71(8):659-65. PubMed ID: 8927468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy in Wilms' tumor--indications and early side effects.
    Boilletot A
    Prog Clin Biol Res; 1982; 100():111-8. PubMed ID: 6292923
    [No Abstract]   [Full Text] [Related]  

  • 17. Massive Wilms' tumor: sonographic demonstration of therapeutic response without alteration in size.
    Shimizu H; Jaffe N; Eftekhari F
    Pediatr Radiol; 1987; 17(6):493-4. PubMed ID: 2825105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vincristine pharmacokinetics after repetitive dosing in children.
    Gidding CE; Meeuwsen-de Boer GJ; Koopmans P; Uges DR; Kamps WA; de Graaf SS
    Cancer Chemother Pharmacol; 1999; 44(3):203-9. PubMed ID: 10453721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An advanced discrete state-discrete event multiscale simulation model of the response of a solid tumor to chemotherapy: Mimicking a clinical study.
    Stamatakos GS; Kolokotroni EA; Dionysiou DD; Georgiadi ECh; Desmedt C
    J Theor Biol; 2010 Sep; 266(1):124-39. PubMed ID: 20515697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wilms' tumor management.
    Wu HY; Snyder HM; D'Angio GJ
    Curr Opin Urol; 2005 Jul; 15(4):273-6. PubMed ID: 15928519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.